ReviewAlzheimer's research & therapy2020

Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval.

Martin Tolar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.